Biologics Center "Device Action Plan" Omits Specific Review Times
This article was originally published in The Gray Sheet
Executive Summary
The FDA Center for Biologics and Research's "Device Action Plan" released April 27 lacks specific review times, making it hard for device manufacturers to evaluate and anticipate the center's review performance, industry reps maintain.